Drug intelligence / Profile preview

nicotinamide + tryptophan

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Nicotinamide + tryptophan is a combination of two nutrients—nicotinamide (a form of vitamin B3) and the essential amino acid tryptophan—used primarily as a dietary supplement. This combination has been studied for its potential antidepressant effects, particularly in patients with unipolar depression. Nicotinamide is included to inhibit the peripheral breakdown of tryptophan by reducing liver tryptophan 2,3-dioxygenase activity, thereby increasing plasma levels of tryptophan and enhancing its availability for serotonin synthesis in the brain. Clinical studies suggest that this combination may be as effective as imipramine (a tricyclic antidepressant) when dosed appropriately, with efficacy linked to increased plasma tryptophan concentrations[1][2][3]. The supplement has also been evaluated alongside vitamin B6 for mood improvement in healthy subjects[3].

Other names
tryptophan-nicotinamide
02

Targets

TDO2 (Tryptophan 2,3-dioxygenase)TPH1 (Tryptophan 5-hydroxylase 1)

Beyond the preview

Go deeper on nicotinamide + tryptophan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nicotinamide + tryptophan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call